Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.600 Biomarker disease BEFREE Therefore, we studied the role of TNF-alpha in fulminant hepatic failure (FHF) and developed a new therapeutic strategy. 10930380 2000
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.600 GeneticVariation disease BEFREE This study examined whether specific tumor necrosis factor polymorphisms are associated with variations in the severity of clinical features in acetaminophen-induced acute liver failure. 9696492 1998
Entrez Id: 540
Gene Symbol: ATP7B
ATP7B
0.440 GeneticVariation disease BEFREE SHED and SHED-Heps were transplanted into WD model Atp7b-mutated Long-Evans Cinnamon (LEC) rats received copper overloading to induce a lethal fulminant liver failure. 30733544 2019
Entrez Id: 540
Gene Symbol: ATP7B
ATP7B
0.440 Biomarker disease CTD_human Wilson disease (WD) is caused by accumulation of excess copper (Cu) due to a mutation in the gene encoding the liver Cu transporter ATP7B, and is characterized by acute liver failure or cirrhosis and neuronal cell death. 25134866 2014
Entrez Id: 540
Gene Symbol: ATP7B
ATP7B
0.440 Biomarker disease BEFREE Wilson disease (WD) is caused by accumulation of excess copper (Cu) due to a mutation in the gene encoding the liver Cu transporter ATP7B, and is characterized by acute liver failure or cirrhosis and neuronal cell death. 25134866 2014
Entrez Id: 540
Gene Symbol: ATP7B
ATP7B
0.440 GeneticVariation disease BEFREE High prevalence of fulminant hepatic failure among patients with mutant alleles for truncation of ATP7B in Wilson's disease. 20491539 2010
Entrez Id: 540
Gene Symbol: ATP7B
ATP7B
0.440 GeneticVariation disease BEFREE We examined the ATP7B gene in two Japanese sisters with Wilson's disease presenting with fulminant hepatic failure but who did not exhibit Kayser-Fleischer rings or abnormal neurological findings. 10777157 2000
Entrez Id: 540
Gene Symbol: ATP7B
ATP7B
0.440 Biomarker disease HPO
Entrez Id: 3082
Gene Symbol: HGF
HGF
0.370 Biomarker disease BEFREE In co-culture, while ALF liver mesenchymal stromal cells (LMSCs) induced the expression of CXCR7, IDI and HGF in human umbilical cord endothelial cells (HUVECs), the ACLF LMSCs were defective and showed decreased production of SDF-1, HGF and MCSF compared to ALF. 31515741 2019
Entrez Id: 3082
Gene Symbol: HGF
HGF
0.370 Biomarker disease BEFREE Treatment with 4-PBA prevented the reduction of HGF in ALF rats. 28844859 2017
Entrez Id: 3082
Gene Symbol: HGF
HGF
0.370 GeneticVariation disease BEFREE Transplantation of human hepatocytes cultured with deleted variant of hepatocyte growth factor prolongs the survival of mice with acute liver failure. 15912107 2005
Entrez Id: 3082
Gene Symbol: HGF
HGF
0.370 Therapeutic disease CTD_human A single administration of adenoviral-mediated HGF cDNA permits survival of mice from acute hepatic failure. 12479984 2003
Entrez Id: 3082
Gene Symbol: HGF
HGF
0.370 AlteredExpression disease BEFREE Liver is unlikely to be the source of the high serum hepatocyte growth factor levels observed in acute liver failure. 11117560 2000
Entrez Id: 3082
Gene Symbol: HGF
HGF
0.370 Biomarker disease BEFREE Lack of its receptor (c-met) expression may explain a poor response of fulminant hepatic failure livers to exogenous hepatocyte growth factor that normally promotes liver growth and regeneration. 9286233 1997
Entrez Id: 3082
Gene Symbol: HGF
HGF
0.370 Biomarker disease BEFREE Mean values for serum HGF in acute hepatitis (AH), chronic hepatitis (CH), liver cirrhosis (LC), hepatocellular carcinoma (HCC), primary biliary cirrhosis (PBC), fulminant hepatic failure (FHF), and normal controls were 0.45, 0.40, 1.05, 1.06, 0.44, 16.40, and 0.27 ng/mL, respectively. 7806142 1995
Entrez Id: 3082
Gene Symbol: HGF
HGF
0.370 Biomarker disease BEFREE The purified HL-60 HGF was indistinguishable from human HGF in the plasma of patients with fulminant hepatic failure by studies of subunit constitution and amino acid composition. 1720310 1991
Entrez Id: 355
Gene Symbol: FAS
FAS
0.350 Biomarker disease BEFREE Transplantation of hBMSCs into <i>Fah<sup>-/-</sup>Rag2<sup>-/-</sup>IL-2Rγc<sup>-/-</sup> SCID</i> (FRGS) mice with fulminant hepatic failure (FHF) induced by hamster-anti-mouse CD95 antibody JO2 generated a liver and immune cell dual-humanised (hBMSC-FRGS) mouse. 30700543 2019
Entrez Id: 355
Gene Symbol: FAS
FAS
0.350 Biomarker disease BEFREE Functional genetics-directed identification of novel pharmacological inhibitors of FAS- and TNF-dependent apoptosis that protect mice from acute liver failure. 26986512 2016
Entrez Id: 355
Gene Symbol: FAS
FAS
0.350 Biomarker disease BEFREE Furthermore, silencing of Fas receptor was effective in blocking or reducing several aspects of ALF when it was tested in mice exposed to galactosamine/lipopolysaccharide (G/L), a well-known model of ALF. 25601293 2015
Entrez Id: 355
Gene Symbol: FAS
FAS
0.350 Biomarker disease CTD_human Increased serum soluble Fas in patients with acute liver failure due to paracetamol overdose. 12828076 2003
Entrez Id: 355
Gene Symbol: FAS
FAS
0.350 AlteredExpression disease LHGDN Involvement of IL-18 and soluble fas in patients with postoperative hepatic failure. 12679613 2003
Entrez Id: 355
Gene Symbol: FAS
FAS
0.350 AlteredExpression disease BEFREE CD95 receptor expression was highly elevated in hepatocytes in hepatitis B virus-related cirrhosis (n = 9) and in acute liver failure (n = 8). 7595193 1995
Entrez Id: 213
Gene Symbol: ALB
ALB
0.340 GeneticVariation disease BEFREE Multivariable analysis showed that a higher initial MELD-Na score (odds ratio [OR], 1.205; 95% confidence interval [CI], 1.018-1.427) and a lower initial serum albumin concentration (OR, 9.35; 95% CI, 1.15-76.9) were associated with increased odds of developing ALF. 31777757 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.340 Biomarker disease BEFREE Absolute quantitation of acetaminophen-modified human serum albumin in acute liver failure patients by liquid chromatography/tandem mass spectrometry. 29920820 2018
Entrez Id: 213
Gene Symbol: ALB
ALB
0.340 GeneticVariation disease BEFREE In conclusion, this study confirmed that SPAD is effective in eliminating albumin-bound as well as water-soluble toxins using a simulation of ALF. 27121702 2017